Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis Type 2
Progressive Vestibular Schwannomas

Interventions

DRUG: Bevacizumab

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]